Spain Consults On HTA Regulations

New rules on health technology assessments in Spain make room for real-world evidence and early dialog.  

Spain
• Source: Alamy

The Spanish health ministry has been asking for feedback on a draft royal decree that would for the first time regulate health technology assessments (HTAs) for health care products in Spain. It would also align the system with the EU HTA Regulation 2021/2282, which introduced EU-level joint clinical assessments.

More from Global Vision

Barcelona Health Hub: Where Digital Health Innovation Meets Historic Art Nouveau

 
• By 

The Barcelona Health Hub is a nonprofit that seeks to advance digital health innovation by bringing together start-ups, investors, health care institutions and corporations.

Reinventing Prevention: Milken Institute Foresees Another Route Using Private And Public Funding

 
• By 

New funding mechanisms are required to give more momentum to prevention in the community and thereby relieve pressure on overburdened health care providers like the UK National Health Service. So says Simon Radford, a director at global thinktank the Milken Institute, which sees a solution in more funding for community-level prevention.

China Medtech: Rapid Localization, Business Model Shift And Market Restriction

 
• By 

China's medical equipment industry is growing rapidly, driven by limited domestic presence in high-cost segments and increasing adoption of local products in areas like monitoring equipment, defibrillators, and ventilators. International giants dominate the high-end market, but domestic companies such as Neusoft Medical Systems and Mindray Medical are making significant strides.

Google Co-Authored Report Lays Out Roadmap For AI In Tackling AMR

 
• By 

Close collaboration between industry, academia and government in employing artificial intelligence could solve the looming threat of antimicrobial resistance, a new report co-authored by Google says.

More from In Vivo

Top 12 Pharma Companies: Pfizer Tops The Leaderboard Again

 

The world’s biggest pharmaceutical companies mostly saw growth in 2024 but 2025 promises to be more of a mixed bag with headwinds including losses of exclusivity, Medicare Part D redesign and challenges in the Chinese market.

Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”

 

Farideh Bischoff, chief medical officer of Heranova Lifesciences, discusses the urgent need for better diagnostic options and the latest innovations transforming care for endometriosis patients.

HealthTech Innovation Versus Clinician And System Awareness

 
• By 

Bringing AI and digital healthtech innovation to patients works most efficiently via a three-way partnership in which clinicians and cloud services have equal weighting with a powerhouse innovator, Royal Philips told In Vivo during ECR 2025.